These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

401 related items for PubMed ID: 3365451

  • 1. Thrombin-induced fibrinopeptide B release from normal and variant fibrinogens: influence of inhibitors of fibrin polymerization.
    Ruf W, Bender A, Lane DA, Preissner KT, Selmayr E, Müller-Berghaus G.
    Biochim Biophys Acta; 1988 May 12; 965(2-3):169-75. PubMed ID: 3365451
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Fibrinopeptide A release is necessary for effective B:b interactions in polymerisation of variant fibrinogens with impaired A:a interactions.
    Soya K, Terasawa F, Okumura N.
    Thromb Haemost; 2013 Feb 12; 109(2):221-8. PubMed ID: 23238100
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Recombinant fibrinogen studies reveal that thrombin specificity dictates order of fibrinopeptide release.
    Mullin JL, Gorkun OV, Binnie CG, Lord ST.
    J Biol Chem; 2000 Aug 18; 275(33):25239-46. PubMed ID: 10837485
    [Abstract] [Full Text] [Related]

  • 6. Fibrinopeptides A and B release in the process of surface fibrin formation.
    Riedel T, Suttnar J, Brynda E, Houska M, Medved L, Dyr JE.
    Blood; 2011 Feb 03; 117(5):1700-6. PubMed ID: 21106983
    [Abstract] [Full Text] [Related]

  • 7. B:b interactions are essential for polymerization of variant fibrinogens with impaired holes 'a'.
    Okumura N, Terasawa F, Haneishi A, Fujihara N, Hirota-Kawadobora M, Yamauchi K, Ota H, Lord ST.
    J Thromb Haemost; 2007 Dec 03; 5(12):2352-9. PubMed ID: 17922804
    [Abstract] [Full Text] [Related]

  • 8. The release of small amounts of fibrinopeptide-B (FPB) is of critical importance for the thrombin clotting time.
    Holm B, Kierulf P, Godal HC.
    Thromb Res; 1986 May 15; 42(4):517-26. PubMed ID: 3715815
    [Abstract] [Full Text] [Related]

  • 9. Fibrinogen Birmingham: a heterozygous dysfibrinogenemia (A alpha 16 Arg----His) containing heterodimeric molecules.
    Siebenlist KR, Prchal JT, Mosesson MW.
    Blood; 1988 Mar 15; 71(3):613-8. PubMed ID: 3345340
    [Abstract] [Full Text] [Related]

  • 10. Fibrinogen Seattle II: congenital dysfibrinogenemia with an Arg (A alpha 16)----his substitution.
    Ebert RF, Schreiler WE, Bell WR.
    Thromb Res; 1986 Jul 01; 43(1):7-13. PubMed ID: 3726812
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Release of fibrinopeptides by the slow and fast forms of thrombin.
    Vindigni A, Di Cera E.
    Biochemistry; 1996 Apr 09; 35(14):4417-26. PubMed ID: 8605191
    [Abstract] [Full Text] [Related]

  • 15. [Interaction of fibrinogen with two forms of fibrin differing in the degree of activation by thrombin].
    Belitser VA, Lugovskoĭ EV, Ugarova TP, Derzskaia SG.
    Biokhimiia; 1985 Aug 09; 50(8):1336-41. PubMed ID: 4074798
    [Abstract] [Full Text] [Related]

  • 16. Substitution of the gamma-chain Asn308 disturbs the D:D interface affecting fibrin polymerization, fibrinopeptide B release, and FXIIIa-catalyzed cross-linking.
    Okumura N, Gorkun OV, Terasawa F, Lord ST.
    Blood; 2004 Jun 01; 103(11):4157-63. PubMed ID: 14764520
    [Abstract] [Full Text] [Related]

  • 17. Functional analysis of recombinant Bbeta15C and Bbeta15A fibrinogens demonstrates that Bbeta15G residue plays important roles in FPB release and in lateral aggregation of protofibrils.
    Hirota-Kawadobora M, Kani S, Terasawa F, Fujihara N, Yamauchi K, Tozuka M, Okumura N.
    J Thromb Haemost; 2005 May 01; 3(5):983-90. PubMed ID: 15869595
    [Abstract] [Full Text] [Related]

  • 18. Thrombin-induced fibrinopeptide release from a fibrinogen variant (fibrinogen Sydney I) with an Aalpha Arg-16----His substitution.
    Southan C, Lane DA, Bode W, Henschen A.
    Eur J Biochem; 1985 Mar 15; 147(3):593-600. PubMed ID: 3979390
    [Abstract] [Full Text] [Related]

  • 19. Fibrinogen Aarhus--a new case of dysfibrinogenemia.
    Hessel B, Stenbjerg S, Dyr J, Kudryk B, Therkildsen L, Blombäck B.
    Thromb Res; 1986 Apr 01; 42(1):21-37. PubMed ID: 2939591
    [Abstract] [Full Text] [Related]

  • 20. Citrullinated fibrinogen shows defects in FPA and FPB release and fibrin polymerization catalyzed by thrombin.
    Okumura N, Haneishi A, Terasawa F.
    Clin Chim Acta; 2009 Mar 01; 401(1-2):119-23. PubMed ID: 19109936
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.